Keywords: medicure, 2nd-qtr, sales, fall, aggrastat, slump, canadian
Medicure's 2nd-qtr sales fall on Aggrastat slump
Article | 21 January 2008
Canadian biopharmaceutical company Medicure says that total product revenue for the three-month period ending November 30, 2007, was C$324,000 ($318,394) versus C$1.4 million ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
